PARP inhibitors – theoretical basis and clinical application
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2012, Vol 66, Issue 0
Abstract
Poly-ADP-ribose polymerases (PARP) are involved in a number of processes that are vital for every living cell. Once activated by the presence of DNA damage they trigger poly-ADP-ribosylation of various proteins which are crucial for DNA repair, preserving of genom integrity, regulation of transcription, proliferation and apoptosis. PARP1, which is the best known enzyme of PARP protein family, plays a role in single-strand breaks (SSB) repair. Decrease of its activity results in accumulation of single strand DNA breaks (SSB) which leads as a consequence to double- strand breaks (DSBs). This disorder is particularly harmful to cells with deficiency of BRCA1/2 protein which is involved in repair of DNA double-strand breaks. This phenomenon is an example of “synthetic lethality” concept and contributes to research on application of PARP inhibitors in treatment of cancers associated with BRCA1/2 protein defect (breast or ovarian cancer). Noticed synergism between PARP inhibitors and genotoxic chemotherapy or radiotherapy determined another direction of research on application of these medicaments. After promising results of phase I and II trials with most commonly investigated PARP inhibitors – iniparib and olaparib- which recruited patients with triple negative breast cancer and ovarian cancer, further studies started. This paper presents theoretical basis of PARP inhibitors action as well as critical review of most important clinical trials of these medicaments.
Authors and Affiliations
Sylwia Dębska, Joanna Kubicka, Rafał Czyżykowski, Maja Habib, Piotr Potemski
Keywords
Related Articles
- EP ID EP66698
- DOI -
- Views 133
- Downloads 0
The discovery of neuromedin U and its pivotal role in the central regulation of energy homeostasis
Neuromedin U (NMU) is a structurally highly conserved neuropeptide and has been paired with the G-protein-coupled receptors (GPCRs) NMUR1 and NMUR2, which were formerly classified in the orphan receptor family. Activati...
Naprawa DNA przez wycinanie zasad azotowych w chorobie Alzheimera
Choroba Alzheimera (AD - Alzheimer Disease), jest najczęstszą chorobą neurodegeneracyjną u ludzi powyżej 65 roku życia. Szacunkowe dane podają, że na AD w Polsce choruje prawie 200 tys. osób, natomiast na świecie na ten...
Choroba Alzheimera a produkty degradacji białka APP. Formowanie i różnorodność form fibrylujących peptydów – wybrane aspekty
Peptydowe produkty degradacji białka APP (Amyloid Precursor Protein, APP), to najważniejsze białka w patofizjologii choroby Alzheimera (Alzheimer’s disease, AD). Choć dobrze już poznane, jednak nadal budzą zainteresowani...
Assessment of the influence of vegetarian diet on the occurrence of erosive and abrasive cavities in hard tooth tissues
Introduction: The aim of the study was to determine the potential relation between vegetarian diet and tooth erosion and abrasion. Material/Methods: The examination included 46 vegetarians and the same number in the cont...
Metody genetyczne w diagnostyce hematoonkologicznej
Zastosowanie różnorodnych technik diagnostycznych, takich jak cytogenetyka klasyczna, cytogenetyka molekularna czy też nowoczesne metody biologii molekularnej w diagnostyce hematoonkologicznej pozwala na poznanie i zrozu...